Pancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis

ISRCTN ISRCTN07091918
DOI https://doi.org/10.1186/ISRCTN07091918
Secondary identifying numbers N/A
Submission date
11/12/2006
Registration date
28/03/2007
Last edited
21/03/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Robin Timmer
Scientific

St Antonius Hospital
Department of Gastroenterology
P.O. Box 2500
Nieuwegein
3402 EM
Netherlands

Email r.timmer@antonius.net

Study information

Study designRandomised controlled multicentre observer-blinded trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titlePancreatitis, ENdoscopic transGastric versUs primary necrosectomy in patients with Infected Necrosis: a randomised controlled multicentre observer-blinded trial (Dutch Acute Pancreatitis Study Group)
Study acronymPENGUIN
Study objectivesEndoscopic transgastric necrosectomy will lead to a reduction of the pre- and post-operative pro-inflammatory response, as compared to necrosectomy by laparotomy, in patients with infected (peri-)pancreatic necrosis.
Ethics approval(s)Regional Medical Ethics Board for the Meander Medical Centre Amersfoort-Baarn-Soest (De Verenigde Commissies Mensgebonden Onderzoek [VCMO]) approved on the 17th April 2007 (ref: LTME/VL-07.08)
Health condition(s) or problem(s) studiedAcute necrotising pancreatitis
InterventionEndoscopic transgastric necrosectomy or necrosectomy by laparotomy, followed by continuous post-operative lavage
Intervention typeOther
Primary outcome measurePro-inflammatory response as measured by the maximum increase in level of serum cytokine Interleukin six (IL-6) in the period between start of the first necrosectomy and five hours thereafter
Secondary outcome measures1. Complications (bleeding, perforation, pancreatic fistula, pancreatic pseudocyst requiring intervention, pancreatic abscess requiring intervention, biliary strictures, incisional hernia requiring re-intervention and pancreatic insufficiency)
2. Mortality
3. Total number of interventions
4. Total hospital stay
5. Total intensive care stay
Overall study start date01/03/2007
Completion date01/03/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target number of participants20
Key inclusion criteria1. Age equal to or above 18 years
2. Pancreatic necrosis or peripancreatic necrosis detected on contrast-enhanced computed tomography (CECT)
3. Patients in whom a decision for surgical intervention has been made because of (suspected) infected (peri-)pancreatic necrosis
4. Safe access route for endoscopic transgastric necrosectomy
5. Written informed consent
Key exclusion criteria1. Participation in another intervention trial that would interfere with the intervention and outcome of this study
2. Previous surgical necrosectomy for (suspected) infected pancreatic necrosis, including procedures performed in referring hospitals. Previous percutaneous or transgastric drainage is allowed
3. Previous exploratory laparotomy for acute abdomen and diagnosis of pancreatitis during laparotomy
4. Acute flare-up of chronic pancreatitis
5. Bleeding, abdominal compartment syndrome or perforation of a visceral organ as indication for intervention
6. Post-abdominal surgery necrotising pancreatitis
Date of first enrolment01/03/2007
Date of final enrolment01/03/2009

Locations

Countries of recruitment

  • Netherlands

Study participating centre

St Antonius Hospital
Nieuwegein
3402 EM
Netherlands

Sponsor information

St Antonius Hospital Nieuwegein (Netherlands)
Hospital/treatment centre

Department of Gastroenterology
P.O. Box 2500
Nieuwegein
3402 EM
Netherlands

Website http://www.antonius.net/rood/english.php
ROR logo "ROR" https://ror.org/01jvpb595

Funders

Funder type

Hospital/treatment centre

University Medical Centre Utrecht (UMCU) (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 14/03/2012 Yes No